Skip to Main Content

Paper Details

Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence.
Expert Rev Vaccines
28
2021

Datasets

Release 1.2